GALANTAMINE SZ galantamine (as hydrobromide) 24mg modified release capsules blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

galantamine sz galantamine (as hydrobromide) 24mg modified release capsules blister pack

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; hypromellose; magnesium stearate; titanium dioxide; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; erythrosine; indigo carmine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

GALANTAMINE SR SCP galantamine (as hydrobromide) 8mg modified release capsules blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

galantamine sr scp galantamine (as hydrobromide) 8mg modified release capsules blister pack

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; ethylcellulose; titanium dioxide; hypromellose; gelatin; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Gazylan XL 8mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gazylan xl 8mg capsules

teva uk ltd - galantamine hydrobromide - modified-release capsule - 8mg

Gazylan XL 16mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gazylan xl 16mg capsules

teva uk ltd - galantamine hydrobromide - modified-release capsule - 16mg

Gazylan XL 24mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gazylan xl 24mg capsules

teva uk ltd - galantamine hydrobromide - modified-release capsule - 24mg

Reminyl Starter Pack 8 mg - 16 mg hard caps. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

reminyl starter pack 8 mg - 16 mg hard caps. prol.-rel.

janssen-cilag sa-nv - galantamine hydrobromide 10,25 mg - eq. galantamine 8 mg (white opaque capsule); galantamine hydrobromide 20,51 mg - eq. galantamine 16 mg (pink opaque capsule) - prolonged-release capsule, hard - 8 mg + 16 mg - galantamine hydrobromide 10.25 mg; galantamine hydrobromide 20.51 mg - galantamine

REMINYL galantamine 24mg (as hydrobromide) modified release capsule Australia - English - Department of Health (Therapeutic Goods Administration)

reminyl galantamine 24mg (as hydrobromide) modified release capsule

janssen-cilag pty ltd - galantamine hydrobromide, quantity: 30.76 mg (equivalent: galantamine, qty 24 mg); galantamine, quantity: 24 mg (equivalent: galantamine hydrobromide, qty 30.76 mg) - capsule, modified release - excipient ingredients: ethylcellulose; hypromellose; diethyl phthalate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid; potassium hydroxide; titanium dioxide; iron oxide yellow; sorbitan monolaurate; iron oxide red; gelatin; sodium lauryl sulfate; macrogol 400; maize starch; sucrose - indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

REMINYL galantamine 16mg (as hydrobromide) modified release capsule Australia - English - Department of Health (Therapeutic Goods Administration)

reminyl galantamine 16mg (as hydrobromide) modified release capsule

janssen-cilag pty ltd - galantamine hydrobromide, quantity: 20.51 mg (equivalent: galantamine, qty 16 mg); galantamine, quantity: 16 mg (equivalent: galantamine hydrobromide, qty 20.51 mg) - capsule, modified release - excipient ingredients: diethyl phthalate; ethylcellulose; hypromellose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; maize starch; sucrose; macrogol 400; titanium dioxide; sorbitan monolaurate; iron oxide red; gelatin; sodium lauryl sulfate; ethanol absolute; sulfuric acid - indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

REMINYL galantamine 8mg (as hydrobromide) modified release capsule Australia - English - Department of Health (Therapeutic Goods Administration)

reminyl galantamine 8mg (as hydrobromide) modified release capsule

janssen-cilag pty ltd - galantamine hydrobromide, quantity: 10.25 mg (equivalent: galantamine, qty 8 mg); galantamine, quantity: 8 mg (equivalent: galantamine hydrobromide, qty 10.25 mg) - capsule, modified release - excipient ingredients: hypromellose; diethyl phthalate; ethylcellulose; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid; maize starch; sucrose; macrogol 400; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate; potassium hydroxide - indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Galantamin Sandoz 8 mg hard caps. prol.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

galantamin sandoz 8 mg hard caps. prol.-rel.

sandoz sa-nv - galantamine hydrobromide 10,25 mg - eq. galantamine 8 mg - prolonged-release capsule, hard - 8 mg - galantamine hydrobromide 10.25 mg - galantamine